Michael Matson
Stock Analyst at Needham
(4.20)
# 1,526
Out of 4,988 analysts
1603
Total ratings
47.9%
Success rate
5.8%
Average return
Main Sectors:
Stocks Rated by Michael Matson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MDT Medtronic | Reiterated: Buy | $114 | $92.13 | +23.74% | 100 | Sep 17, 2026 | |
| VCYT Veracyte | Reiterated: Buy | $69 | $39.80 | +73.39% | 37 | Sep 15, 2026 | |
| TMDX TransMedics Group | Reiterated: Buy | $106 | $86.42 | +22.66% | 30 | Sep 11, 2026 | |
| ATRC AtriCure | Reiterated: Buy | $45 → $64 | $58.10 | +10.15% | 104 | Sep 2, 2026 | |
| ENOV Enovis | Reiterated: Buy | $52 | $18.04 | +188.25% | 19 | Sep 1, 2026 | |
| TFX Teleflex | Rated: Buy | $159 → $170 | $124.52 | +36.52% | 72 | Aug 25, 2026 | |
| HAE Haemonetics | Reiterated: Hold | n/a | $108.40 | - | 48 | Aug 18, 2026 | |
| IMDX Insight Molecular Diagnostics | Reiterated: Buy | $9 | $4.03 | +123.33% | 37 | Aug 18, 2026 | |
| PLSE Pulse Biosciences | Initiated Coverage: Buy | $58 | $53.87 | +7.67% | 1 | Aug 17, 2026 | |
| LUCD Lucid Diagnostics | Reiterated: Buy | $3 | $0.7857 | +281.83% | 33 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $44 | $23.35 | +88.44% | 61 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $165 → $187 | $152.65 | +22.50% | 14 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $12 | $5.14 | +133.46% | 87 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $224.99 | - | 96 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $86 → $95 | $69.30 | +37.09% | 11 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $16.40 | - | 40 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $205.04 | - | 34 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $14.35 | - | 42 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 → $35 | $21.82 | +60.40% | 52 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $81 → $93 | $78.01 | +19.22% | 87 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $95.36 | - | 89 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $90 → $101 | $85.37 | +18.31% | 69 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $418 | $275.12 | +51.93% | 74 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $45.42 | - | 83 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $57 | $43.34 | +31.52% | 128 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $15 → $19 | $19.91 | -4.57% | 39 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $317.60 | - | 24 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.035 | n/a | 2 | Apr 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $65 → $82 | $74.08 | n/a | 22 | May 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $27 | $18.09 | n/a | 1 | Mar 18, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $4.77 | n/a | 50 | Dec 6, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1.73 | n/a | 10 | Nov 11, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1 | $9.11 | n/a | 1 | Nov 6, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $636 | $393.33 | n/a | 1 | Apr 19, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $15 → $14 | $10.54 | n/a | 4 | Apr 9, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $8.71 | n/a | 1 | Apr 17, 2009 |
Medtronic
Sep 17, 2026
Reiterated: Buy
Price Target: $114
Current: $92.13
Upside: +23.74%
Veracyte
Sep 15, 2026
Reiterated: Buy
Price Target: $69
Current: $39.80
Upside: +73.39%
TransMedics Group
Sep 11, 2026
Reiterated: Buy
Price Target: $106
Current: $86.42
Upside: +22.66%
AtriCure
Sep 2, 2026
Reiterated: Buy
Price Target: $45 → $64
Current: $58.10
Upside: +10.15%
Enovis
Sep 1, 2026
Reiterated: Buy
Price Target: $52
Current: $18.04
Upside: +188.25%
Teleflex
Aug 25, 2026
Rated: Buy
Price Target: $159 → $170
Current: $124.52
Upside: +36.52%
Haemonetics
Aug 18, 2026
Reiterated: Hold
Price Target: n/a
Current: $108.40
Upside: -
Insight Molecular Diagnostics
Aug 18, 2026
Reiterated: Buy
Price Target: $9
Current: $4.03
Upside: +123.33%
Pulse Biosciences
Aug 17, 2026
Initiated Coverage: Buy
Price Target: $58
Current: $53.87
Upside: +7.67%
Lucid Diagnostics
Aug 13, 2026
Reiterated: Buy
Price Target: $3
Current: $0.7857
Upside: +281.83%
Aug 7, 2026
Reiterated: Buy
Price Target: $44
Current: $23.35
Upside: +88.44%
Aug 7, 2026
Rated: Buy
Price Target: $165 → $187
Current: $152.65
Upside: +22.50%
Aug 7, 2026
Rated: Buy
Price Target: $12
Current: $5.14
Upside: +133.46%
Aug 7, 2026
Reiterated: Hold
Price Target: n/a
Current: $224.99
Upside: -
Aug 6, 2026
Reiterated: Buy
Price Target: $86 → $95
Current: $69.30
Upside: +37.09%
Aug 6, 2026
Reiterated: Hold
Price Target: n/a
Current: $16.40
Upside: -
Aug 6, 2026
Reiterated: Hold
Price Target: n/a
Current: $205.04
Upside: -
Aug 5, 2026
Reiterated: Hold
Price Target: n/a
Current: $14.35
Upside: -
Aug 5, 2026
Reiterated: Buy
Price Target: $30 → $35
Current: $21.82
Upside: +60.40%
Aug 5, 2026
Reiterated: Buy
Price Target: $81 → $93
Current: $78.01
Upside: +19.22%
Aug 5, 2026
Reiterated: Hold
Price Target: n/a
Current: $95.36
Upside: -
Jul 31, 2026
Reiterated: Buy
Price Target: $90 → $101
Current: $85.37
Upside: +18.31%
Jul 31, 2026
Reiterated: Buy
Price Target: $418
Current: $275.12
Upside: +51.93%
Jul 30, 2026
Reiterated: Hold
Price Target: n/a
Current: $45.42
Upside: -
Jul 29, 2026
Reiterated: Buy
Price Target: $57
Current: $43.34
Upside: +31.52%
Jul 29, 2026
Rated: Buy
Price Target: $15 → $19
Current: $19.91
Upside: -4.57%
Feb 25, 2026
Reiterated: Hold
Price Target: n/a
Current: $317.60
Upside: -
Apr 5, 2024
Downgraded: Hold
Price Target: n/a
Current: $0.035
Upside: n/a
May 5, 2021
Reiterated: Buy
Price Target: $65 → $82
Current: $74.08
Upside: n/a
Mar 18, 2020
Reiterated: Buy
Price Target: $27
Current: $18.09
Upside: n/a
Dec 6, 2018
Rated: Hold
Price Target: n/a
Current: $4.77
Upside: n/a
Nov 11, 2016
Reiterated: Buy
Price Target: n/a
Current: $1.73
Upside: n/a
Nov 6, 2015
Reiterated: Buy
Price Target: $1
Current: $9.11
Upside: n/a
Apr 19, 2013
Reiterated: Buy
Price Target: $636
Current: $393.33
Upside: n/a
Apr 9, 2013
Upgraded: Buy
Price Target: $15 → $14
Current: $10.54
Upside: n/a
Apr 17, 2009
Downgraded: Sell
Price Target: n/a
Current: $8.71
Upside: n/a